中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2015年
1期
40-43
,共4页
陈宇%刘昌伟%刘志丽%吴巍巍%曾嵘%宋小军%刘暴
陳宇%劉昌偉%劉誌麗%吳巍巍%曾嶸%宋小軍%劉暴
진우%류창위%류지려%오외외%증영%송소군%류폭
动脉闭塞性疾病%血管成形术%动脉导管
動脈閉塞性疾病%血管成形術%動脈導管
동맥폐새성질병%혈관성형술%동맥도관
Arterial occlusive diseases%Angioplasty%Ductus Arteriosus
目的 评估利用Reekross球囊导管开通长段髂股动脉闭塞性病变的安全性和有效性.方法 选取北京协和医院2011年1月至2013年5月应用Reekross球囊导管进行血管腔内治疗的68例髂股动脉长段慢性闭塞病变(CTO)患者(75条肢体),所有患者均为泛太平洋协作组共识(TASC)ⅡC、D级.其中男53例,女15例;年龄47 ～ 89(69±12)岁.肢体按Rutherford下肢缺血分期为3期41条,4期13条,5期19条,6期2条.总结分析技术成功率、患肢术后临床症状、踝肱指数(ABI)变化、并发症发生率及通畅率.结果 Reekross球囊导管开通病变技术成功率为90.7％(68/75),ABI从术前的(0.41±0.12)提升至术后3d的(0.77±0.20),差异有统计学意义(t=-7.263,P＜0.01).56例患者(61条肢体)随访12～40个月,平均(26.3±7.1)个月.术后3、6、12及24个月累计一期通畅率分别为(98.4±1.6)％、(86.7±4.4)％、(80.0±5.2)％及(69.4±6.3)％.结论 Reekross球囊导管在治疗髂股动脉CTO病变中具有良好的应用价值,方法安全有效.
目的 評估利用Reekross毬囊導管開通長段髂股動脈閉塞性病變的安全性和有效性.方法 選取北京協和醫院2011年1月至2013年5月應用Reekross毬囊導管進行血管腔內治療的68例髂股動脈長段慢性閉塞病變(CTO)患者(75條肢體),所有患者均為汎太平洋協作組共識(TASC)ⅡC、D級.其中男53例,女15例;年齡47 ～ 89(69±12)歲.肢體按Rutherford下肢缺血分期為3期41條,4期13條,5期19條,6期2條.總結分析技術成功率、患肢術後臨床癥狀、踝肱指數(ABI)變化、併髮癥髮生率及通暢率.結果 Reekross毬囊導管開通病變技術成功率為90.7％(68/75),ABI從術前的(0.41±0.12)提升至術後3d的(0.77±0.20),差異有統計學意義(t=-7.263,P＜0.01).56例患者(61條肢體)隨訪12～40箇月,平均(26.3±7.1)箇月.術後3、6、12及24箇月纍計一期通暢率分彆為(98.4±1.6)％、(86.7±4.4)％、(80.0±5.2)％及(69.4±6.3)％.結論 Reekross毬囊導管在治療髂股動脈CTO病變中具有良好的應用價值,方法安全有效.
목적 평고이용Reekross구낭도관개통장단가고동맥폐새성병변적안전성화유효성.방법 선취북경협화의원2011년1월지2013년5월응용Reekross구낭도관진행혈관강내치료적68례가고동맥장단만성폐새병변(CTO)환자(75조지체),소유환자균위범태평양협작조공식(TASC)ⅡC、D급.기중남53례,녀15례;년령47 ～ 89(69±12)세.지체안Rutherford하지결혈분기위3기41조,4기13조,5기19조,6기2조.총결분석기술성공솔、환지술후림상증상、과굉지수(ABI)변화、병발증발생솔급통창솔.결과 Reekross구낭도관개통병변기술성공솔위90.7％(68/75),ABI종술전적(0.41±0.12)제승지술후3d적(0.77±0.20),차이유통계학의의(t=-7.263,P＜0.01).56례환자(61조지체)수방12～40개월,평균(26.3±7.1)개월.술후3、6、12급24개월루계일기통창솔분별위(98.4±1.6)％、(86.7±4.4)％、(80.0±5.2)％급(69.4±6.3)％.결론 Reekross구낭도관재치료가고동맥CTO병변중구유량호적응용개치,방법안전유효.
Objective The purpose of this study was to examine the safety and efficacy of the Reekross balloon catheter for recanalization of long CTO of iliofemoral arteries.Methods A retrospective analysis of patients with long CTO of iliofemoral arteries who underwent angioplasty with Reekross balloon catheter between January 2011 and May 2013 was performed.All lesions were TASC Ⅱ C and D.Sixty-eight patients(75 limbs) were enrolled with mean age of (69 ± 12)years,53 male and 15 female.The limbs of Rutherford Ⅲ,Ⅳ,Ⅴ and Ⅵ[were 41,13,19 and 2.Technical successrate,ankle brachial index (ABI),complication rate,and cumulative primary patency rate were evaluated.Results Technical success ratewas 90.7％.ABI increased from pre-procedure (0.41 ± 0.12) to 3-day post-procedure (0.77 ± 0.20) (t =-7.263,P ＜0.01).Follow-up was achieved in 56 cases(61 limbs) from 12 to 40 months,with a mean of (26.3 ± 7.1)months.Primary patency rates at 3 months,6 months,12 months and 24 months were (98.4 ± 1.6) ％,(86.7 ± 4.4) ％,(80.0 ± 5.2) ％ and (69.4 ± 6.3) ％.Conclusion The Reekross balloon catheter is safe and effective for successful recanalization of CTO of iliofemoral artery.
